The relative scores for all mood stabilizers showed an increasing trend, with the most notable increase observed for lithium carbonate, which more than doubled (2015, 0.61; 2022, 1.26; Figure 1b ).
← all excerpts
Comparison of bipolar disorder patients' evaluation of their treatment in 2015 and 2022.
1
—
—